PNC Financial Services Group
CTKB icon

PNC Financial Services Group’s Cytek Biosciences CTKB Stock Holding History

PNC Financial Services Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.3K Buy
17,927
+1,590
+10% +$7.51K ﹤0.01% 2969
2025
Q4 		$82.5K Sell
16,337
-987
-6% -$4.58K ﹤0.01% 2926
2025
Q3 		$60.1K Buy
17,324
+846
+5% +$3.18K ﹤0.01% 3100
2025
Q2 		$56K Buy
16,478
+12,662
+332% +$42.2K ﹤0.01% 3047
2025
Q1 		$15.3K Sell
3,816
-5,034
-57% -$26.1K ﹤0.01% 3660
2024
Q4 		$57.4K Buy
8,850
+4,665
+111% +$27.8K ﹤0.01% 3023
2024
Q3 		$23.2K Sell
4,185
-2,587
-38% -$14.7K ﹤0.01% 3441
2024
Q2 		$37.8K Buy
6,772
+3,024
+81% +$18.2K ﹤0.01% 3164
2024
Q1 		$25.1K Sell
3,748
-2,347
-39% -$18.6K ﹤0.01% 3331
2023
Q4 		$55.6K Sell
6,095
-2,267
-27% -$14.3K ﹤0.01% 2917
2023
Q3 		$46.2K Buy
8,362
+1,150
+16% +$9.22K ﹤0.01% 3002
2023
Q2 		$61.6K Buy
7,212
+6,777
+1,558% +$60.8K ﹤0.01% 2932
2023
Q1 		$4K Hold
435
– – ﹤0.01% 4108
2022
Q4 		$4.44K Hold
435
– – ﹤0.01% 4026
2022
Q3 		$6K Hold
435
– – ﹤0.01% 3914
2022
Q2 		$5K Hold
435
– – ﹤0.01% 3986
2022
Q1 		$5K Hold
435
– – ﹤0.01% 3989
2021
Q4 		$7K Buy
+435
New +$9.11K ﹤0.01% 3871

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PNC Financial Services Group's CTKB Position: Q1 2026 in Review

PNC Financial Services Group increased its Cytek Biosciences (CTKB) stake by 9.7% in Q1 2026, buying an estimated $7.51K and bringing the position to 17,927 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

PNC Financial Services Group first reported a position in CTKB in Q4 2021 and has held it in 18 quarters since. The position peaked at $82.5K in Q4 2025. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • PNC Financial Services Group held 17,927 shares of Cytek Biosciences worth $78.3K as of Q1 2026.
  • PNC Financial Services Group bought 1,590 Cytek Biosciences shares in Q1 2026, an estimated $7.51K.
  • Cytek Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #2969 holding.
  • PNC Financial Services Group first reported a position in Cytek Biosciences in Q4 2021 and has held it in 18 quarters since.
  • PNC Financial Services Group's Cytek Biosciences position peaked at $82.5K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.